about
What advances have been made in immune-therapy for renal cell carcinoma?Basis for molecular diagnostics and immunotherapy for esophageal cancer.Resistance to anticancer immunity in cancer patients: potential strategies to reverse resistance.PD-1/PD-L1 expression in chromophobe renal cell carcinoma: An immunological exception?Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity.Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis.Targeting immune checkpoints in breast cancer: an update of early results.
P2860
Q38759282-6703B01F-471C-4A36-AEB2-1C5D59E31303Q39006844-6827979B-4163-4E14-BFE2-57F0A7CFCF51Q39013616-C0A17A01-69E3-4F1E-B519-8DB1DAA26731Q39329024-6793F921-2EA5-408F-B20B-6BA1DB4C0C2BQ45968787-CA2CFA37-778B-4D48-9C7B-9E1E1F8AFD2FQ47136435-CE45D6BB-3B53-4D6B-86BE-DAE7A77E5337Q55182988-E625F2C3-5029-462D-AE7E-7EBE6694A8C3
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Immunotherapy advances in uro-genital malignancies.
@en
type
label
Immunotherapy advances in uro-genital malignancies.
@en
prefLabel
Immunotherapy advances in uro-genital malignancies.
@en
P50
P1476
Immunotherapy advances in uro-genital malignancies.
@en
P2093
Daniele Raggi
P356
10.1016/J.CRITREVONC.2016.06.012
P50
P577
2016-06-17T00:00:00Z